First outpatient clinical trial of a full closed-loop artificial pancreas system in South America

"The first two studies of an artificial pancreas (AP) system carried out in Latin America took place in 2016 (phase 1) and 2017 (phase 2). They evaluated a hybrid algorithm from the University of Virginia (UVA) and the automatic regulation of glucose (ARG) algorithm in an inpatient setting usin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Garelli, Fabricio, Fushimi, Emilia, Rosales, Nicolás, Arambarri, Delfina, Mendoza, Leandro, Serafini, María Cecilia, Moscoso-Vásquez, Marcela, Stasi, Marianela, Duette, Patricia, García Arabehety, Julia, Giunta, Javier, De Battista, Hernán, Sánchez-Peña, Ricardo, Grosembacher, Luis
Formato: Artículo de Publicación Periódica acceptedVersion
Lenguaje:Inglés
Publicado: 2023
Materias:
ORGANOS ARTIFICIALES
PANCREAS
ENSAYOS CLINICOS
INSULINA
Acceso en línea:https://ri.itba.edu.ar/handle/123456789/4134
Aporte de:
Repositorio Institucional Instituto Tecnológico de Buenos Aires (ITBA) de Instituto Tecnológico de Buenos Aires (ITBA)
Descripción
Sumario:"The first two studies of an artificial pancreas (AP) system carried out in Latin America took place in 2016 (phase 1) and 2017 (phase 2). They evaluated a hybrid algorithm from the University of Virginia (UVA) and the automatic regulation of glucose (ARG) algorithm in an inpatient setting using an AP platform developed by the UVA. The ARG algorithm does not require carbohydrate (CHO) counting and does not deliver meal priming insulin boluses. Here, the first outpatient trial of the ARG algorithm using an own AP platform and doubling the duration of previous phases is presented."

Ejemplares similares